Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Perinatal Brain Injury
NCT05590676Phase 1Terminated
- Sponsor
- SickKids
- Start
- May 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of metformin in hypoxic-ischemic encephalopathy (HIE) and preterm birth (4 arms), sponsored by SickKids. Primary endpoint: Number of patients with hypoglycemia at 2 weeks. Started May 2023; status: terminated.
02
Drugs
metformin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)preterm birth
Beyond the preview
Go deeper on NCT05590676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590676.